Target- |
Mechanism- |
|
|
|
Inactive Indication- |
Drug Highest PhaseDiscovery |
First Approval Ctry. / Loc.- |
First Approval Date- |
100 Clinical Results associated with Hefei KS-V Peptide Biological Technology Co., Ltd.
0 Patents (Medical) associated with Hefei KS-V Peptide Biological Technology Co., Ltd.
19 May 2023·Organic letters
Chemical Synthesis of Proteins Using an o-Nitrobenzyl Group as a Robust Temporary Protective Group for N-Terminal Cysteine Protection
Article
Author: Zhang, Yan-Ni ; Xie, Xiao-Lei ; Qi, Jing-Ze ; Zhang, Suo-De ; Wan, Xiao-Cui ; Fang, Ge-Min
We report here a robust and practical strategy for chemical protein synthesis using an o-nitrobenzyl group as a temporary protective group for an N-terminal cysteine residue of intermediate hydrazide fragments. By reinvestigating the photoremoval of an o-nitrobenzyl group, we establish a robust and reliable strategy for its quantitative photodeprotection. The o-nitrobenzyl group is completely stable to oxidative NaNO2 treatment and has been applied to the convergent chemical synthesis of programmed death ligand 1 fragment, providing a practical avenue for hydrazide-based native chemical ligation.
ORGANIC & BIOMOLECULAR CHEMISTRY
Generation of antibody–drug conjugates by proximity-driven acyl transfer and sortase-mediated ligation
Article
Author: Xue, Jun-Hao ; Cui, Zhi-Hui ; Wang, Yu-Xuan ; Zhang, Hua ; Zheng, Feng-Hao ; Fang, Ge-Min ; Xie, Xiao-Lei ; Yin, Qing-Hong ; Zhou, Li ; Wang, Tao
We report a sortase-based site-specific antibody–drug conjugation strategy involving an affinity peptide-directed acyl transfer reaction and the sortase-mediated peptide ligation that allows for the attachment of protein-based payloads to antibodies.
Chemical communications (Cambridge, England)
Total stepwise solid-phase synthesis of peptide–oligonucleotide conjugates using side-chain Boc/tBu protecting groups
Article
Author: Wang, Tao ; Sun, Demeng ; Tian, Changlin ; Fang, Gemin ; Cao, Xiuxiu ; Chen, Chenchen ; Zheng, Yong ; Zhou, Li
A practical strategy for the total stepwise solid-phase synthesis of peptide–oligonucleotide conjugates was developed, which will expand the applicability of this strategy in the preparation of peptide–oligonucleotide conjugates.
100 Deals associated with Hefei KS-V Peptide Biological Technology Co., Ltd.
100 Translational Medicine associated with Hefei KS-V Peptide Biological Technology Co., Ltd.